SIMA LABS is NABL accredited and approved under FSSR and BIS for the complete testing and analysis of finished pharmaceutical products. All testing is performed in accordance with global pharmacopeial standards such as IP, USP, BP, EP, and WHO guidelines, ensuring results are accepted by domestic regulatory bodies and international authorities for product release, market compliance, and export certification.

We offer end-to-end testing solutions for all finished dosage forms to verify their quality, safety, efficacy, and compliance before they enter the market.

Scope of Testing:

• Dosage Forms Covered:

  • Tablets & capsules

  • Oral liquids (syrups, suspensions)

  • Injectables (liquid & lyophilized)

  • Topicals (creams, ointments, gels)

  • Powders, granules, and novel drug delivery systems

Parameters Tested:

• Identity & assay of active ingredients

• Uniformity of dosage units

• Dissolution & disintegration studies

• Related substances & impurities profiling

• Stability testing (accelerated & long-term)

• Microbiological analysis & sterility testing

• pH, viscosity, and organoleptic properties

Technology Used:

• HPLC, GC, UV-Vis, FTIR, ICP-MS, Dissolution Testers

• Microbiology labs with cleanroom facilities for sterile product testing

Regulatory Compliance:

• Indian Pharmacopoeia (IP)

• United States Pharmacopoeia (USP)

• British Pharmacopoeia (BP)

• European Pharmacopoeia (EP)

• WHO guidelines for pharmaceutical quality

With validated methods, skilled analysts, and state-of-the-art facilities, SIMA LABS ensures your finished products meet the highest global quality standards before they reach the market.